scPharmaceuticals Inc. (SCPH) Financials
SCPH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 94.5 million | 57.3 million |
2023-09-30 | 106.1 million | 57.0 million |
2023-06-30 | 114.2 million | 50.7 million |
2023-03-31 | 127.4 million | 51.6 million |
SCPH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -15.2 million | 1.4 million |
2023-09-30 | -13.5 million | 1.3 million |
2023-06-30 | -14.1 million | 1.2 million |
2023-03-31 | -16.5 million | 980000 |
SCPH Net Income
No data available :(
SCPH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 76.0 million | - | 1.5 million |
2023-09-30 | 90.2 million | - | 1.6 million |
2023-06-30 | 102.9 million | - | 271000 |
2023-03-31 | 116.1 million | 37.3 million | 424000 |
SCPH Shares Outstanding
SCPH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 37000 | 3.3 million | 16.2 million | - |
2023-09-30 | - | 3.4 million | 14.1 million | - |
2023-06-30 | 3000 | 2.9 million | 12.1 million | - |
2023-03-31 | 3000 | 2.1 million | 10.9 million | - |
SCPH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 6.1 million | 1.8 million |
2023-09-30 | 3.8 million | 1.1 million |
2023-06-30 | 1.6 million | 354000 |
2023-03-31 | 2.1 million | 605000 |
SCPH
Price: $4.71
52 week price:
Earnings Per Share: -1.42 USD
P/E Ratio: -4.15
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 152000
Market Capitalization: 176.7 million